Learn More About Our Oncology Expertise

oncology trials resources

Mastering Oncology Immunotherapy Clinical Trials

 

 

For your convenience, our white papers, overviews and fact sheets can be accessed here.

RFP Guide to Oncology Clinical Trials

This ebook is an RFP planning guide for small to mid-sized oncology sponsors Understanding the primary cost drivers for oncology clinical studies can be daunting. Novella Clinical developed this guide to help smaller oncology sponsors better understand the nuances of … Read More

The Promise of Liquid Biopsy Technology

Utilizing Investigational Technologies in Oncology Trials New technologies are changing oncology research – not only for cancer researchers but for patients. This paper explores the potential of liquid biopsies across diagnostics, therapy monitoring and disease recurrence from a clinical development … Read More

Immuno-Oncology Overview

Supporting Your Complex Immuno-Oncology Trials Our experienced project teams and custom approach to serving biopharma companies enable us to support the complex nature of immunotherapy trials from first-in-human trials to registration. Novella’s oncology teams have conducted more than 140 oncology … Read More

CRISPR-Cas9: Catalyst for Oncology Clinical Trials?

Harnessing Gene-Editing Technology for Oncology Trials The gene-editing technology has captured the attention of the life science and investment communities not only as an elegant tool in the classical science sense — simple and precise — but also as efficient and easy … Read More

Patient Enrollment Overview

Methodology for Strategic Enrollment Projections Enrollment projections are critically important to biopharma companies with limited resources. The two primary drivers of realistic patient enrollment projections are data and experience. Novella Clinical utilizes both to develop strategic enrollment projections with a … Read More

Case Study: Study Start-Up and Enrollment

Novella Clinical’s rapid start-up and enrollment sets the course for successful execution of this Phase II prostate cancer drug trial Novella Clinical was approached by a clinical-stage biopharmaceutical company to run its Phase II prostate cancer drug trial in the US. … Read More

The Nuances of Hematological Oncology Clinical Trials

Investigating Candidate Treatments for Blood Cancers Today, conducting good clinical trials in hematological malignancies requires an understanding of a rapidly evolving treatment paradigm that is increasingly nuanced, complex and patient-directed. Sponsors developing hematological oncology therapies must capitalize on the principles … Read More

Planning for Success: Global Oncology Trials

Explore Factors Most Critical to the Success of Late Phase Oncology Trials Many pharmaceutical, biotechnology and medical device companies have adopted globalization as a business model for their clinical trials. This model is especially pertinent within oncology with the number … Read More

Oncology Data Review

Re-Imagine Oncology Data Management Clinical trial data technology (specifically electronic data capture, remote data review and advanced data visualization) combined with risk-based approaches to clinical monitoring presents sponsors, CROs and research sites with the opportunity to rethink traditional data management, … Read More

Optimizing Early Phase Oncology Clinical Trials

Driving Down Early Phase Oncology Protocol Amendments Oncology product development continues to dominate the global therapeutics market. This strength depends not only on continued use of existing products but also on the clinical and regulatory success of candidates now under … Read More

Oncology Overview

Helping You Improve the Lives of People With Cancer Novella Clinical is a global, full-service clinical research organization (CRO) serving small and mid-sized oncology sponsors as a trusted outsourcing partner since 1998. Having implemented more than 450 oncology trials to … Read More

Oncology Hematology Overview

Dedicated Expertise in Your Fight Against Blood Cancers Novella has dedicated hematology / oncology teams and processes to support hematologic studies. Our specialists understand the clinical implications of blood-based cancers, the diverse pathologies, complex assessments, sick patient population, and lab-based endpoints inherent … Read More

Genitourinary Oncology Overview

Specialists Ready to Advance Your Next Genitourinary Trial. Genitourinary (GU) oncology is one of Novella’s largest areas of focus. More than 65% of our oncology trials have targeted solid tumor indications, including a number of rare cancers such as non-muscle … Read More